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Dr. Stitt stated he felt that Dr. Mitchell's generalization, that large animals such as
sheep did not produce fevers in response to intracerebral injections of PGE, was
inaccurate, since there were at least two reports in the literature by Bligh and Milton
and by Hales that documented such fevers. Dr. Mitchell acknowledged this fact, but
added that these injections of PGE were given intracerebroventricularly, rather than
into the hypothalamic tissue.
Dr. Bernheim stated that he was puzzled by Dr. Mitchell's suggestion that the
mediator offever was a prostanoid other than PGE. He pointed out Dr. Mitchell's own
data, showing that salicylate treatment could suppress PGE rises in the cisternal
cerebrospinal fluid, but not fever, in response to pyrogen. He felt that Dr. Mitchell's
interpretation of the data, which he did not necessarily agree with, would rule out all
prostanoids, not just PGE, since salicylate blocks all cyclooxygenase products of the
arachidonic acid pathway. He also pointed out that experiments on the pathogenesis of
fever that used the intracerebroventricular route for injecting pyrogen to produce fever
were suspect, because of the marked differences between the latency and duration of
fevers produced by this method compared to those produced by the intravenous route.
Dr. Mitchell conceded that the process that occurs when pyrogen is injected into the
cerebral ventricles is different from the process that occurs when it is injected into the
systemic circulation; however, he refused to concede that it had been proven that PGE
was involved in either process.
Dr. Coceani, who said he was really a proponent of the PGE role in the guise of an
opponent, felt that he could comment on both sides ofthe argument. He acknowledged
that it was a paradox that fevers produced by intrathecal injections of IL-1 were
delayed and slower in progression than those produced by intravenous injections of
IL-1. However, we must realize that the direct injection of IL-I into the brain is a very
drastic insult and for the sake of argument, we could postulate that such a procedure
could also stimulate the release ofhydroperoxides ofprostanoic acid which, it is known,
can interfere with the activation of, or even deactivate, cyclooxygenase. This process in
turn could alter the kinetics ofthe subsequent febrile response. On the other side ofthe
argument, he was troubled by Dr. Mitchell's experiments using arachidonic acid to
produce fever. First, they required microgram quantities of arachidonic acid, com-
pared to nanogram amounts of PGE. Second, arachidonic acid, in common with all
fatty acids, acts as a detergent and may itself be an activator of phospholipase. Thus,
when we are dealing with arachidonic acid and we assume that there is an effect of
anisomycin on the cyclooxygenase because we see a decrease, what we may actually be
observing is a depression ofthe phospholipase A2 that was activated by the arachidonic
acid. It is also known that exogenous arachidonic acid can stimulate the formation of
prostanoids from endogenous arachidonic acid. He also had reservations about the
experiments involving prostaglandin antagonists. He was not convinced that it could be
assumed that the prostaglandin antagonists actually inhibit the action ofendogenously
formed PGE2. Just because exogenously applied PGE2 could be inhibited by the
antagonist did not mean that the same was true ofendogenously produced PGE2. It is
well known that cyclooxygenase is present in both the cell membranes and the
endoplasmic reticulum. For the sake ofargument, it could be supposed that PGE2 can
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cross the cell membrane quite easily, but the antagonist cannot, because it is very
insoluble. Thus, if PGE were formed endogenously within the cell's endoplasmic
reticulum, it could act at a site that was not accessible to the antagonist.
Dr. Hellon remarked that both sides of the debate seemed to have produced totally
concrete and complete cases and, therefore, the answer must lie somewhere in the
middle. He wished to defend the prostaglandin antagonist experiments that were
described by Dr. Mitchell and criticized by all of the other speakers. Because of the
insolubility ofthese substances, they had to be injected intracerebroventricularly along
with the pyrogen. While Dr. Coceani's objections could not be adequately dealt with
yet, he felt that they raised the larger problem: that we were trying to look at very
localized molecular processes within the cellular membranes, using techniques that
were really too crude to resolve them. The real problem was to devise methods that
were more refined and selective. This situation applied to all techniques, whether they
involved microinjections, intraventricular injections, or chopped-up tissues.
Dr. Blatteis concurred with the idea that the OVLT was a likely site for the entry of
pyrogen into the brain, since he had evidence that destruction of this area in guinea
pigs made them refractory to fever. He had difficulty in visualizing the OVLT as the
actual site of action of the pyrogen or PGE in the production of fever, however,
especially since it had been shown that injection of IL-I into the preoptic area evoked
fever. Dr. Stitt replied that his reason for postulating that the OVLT was the site of
action of PGE was based on the higher fever sensitivity of this region to microinjected
PGE compared to the preoptic area.
Dr. Kluger inquired whether the paper by Pittman et al. on fever in neonatal lambs,
referred to by Dr. Mitchell, reported differential responses between the effects of IL-I
and PGE in the production of fever. Dr. Mitchell replied that the experimenter had
only used endotoxin and PGE in these experiments and had shown that while it took
three to four days after birth and repeated injections before the lambs displayed fever
in response to endotoxin, in many cases the animals responded to PGE within hours of
birth.
Dr. Duffremarked that the very strong case made by Dr. Stitt and Dr. Bernheim for
a role for PGE in the mediation of fever rested largely on the specialized function
ascribed to the OVLT. In particular, he was interested in the nature of the cells that
Dr. Stitt postulated as being the transducers of the IL-I signal. At different times
during his presentation, Dr. Stitt referred to them as mesenchymal cells, macrophages,
and dendritic cells. Since these terms are fairly well-defined names for immunologi-
cally active cells and carry with them specific implications, Dr. Duff wished to know
whether the terms were used to imply descriptive or functional aspects of the cells. Dr.
Stitt replied that he was aware of these connotations and the term dendritic cell was
used primarily in a descriptive manner, based on the opinion of a colleague who had
worked with the immunologically active dendritic cells first described by Steinman in
the spleen. Based on the studies of Sano and Murabe, however, there was also evidence
that these cells possessed the ability to imbibe large molecules such as horseradish
peroxidase and therefore there were functional aspects to be considered also. Dr. Duff
then asked whether these cells might also release PGE in response to other pyrogens
such as endotoxin or interferon. Dr. Stitt replied that he had not investigated the
effects of interferon, but he suspected that endotoxin in large enough quantities might
be effective in releasing PGE. He felt that this theory might explain the paradox that
large quantities of intravenously injected endotoxin have been reported to cause fevers
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with a latency of onset that was as short as that reported for IL-1. This finding, of
course, was in contrast to the normal sequence of endotoxin fever which, in smaller
quantities, is thought to act through the initial release of IL-I and therefore had a
much longer latency to fever onset. Dr. Atkins recalled the early experiments ofWood
and King, which first demonstrated that endogenous pyrogen injected into the carotid
artery acted more rapidly to cause fever that it did when injected intravenously. He
stated that they could find no difference in the latency of the fevers produced by
endotoxin when it was injected by either ofthese routes, and this fact would not fit with
Dr. Stitt's hypothesis. Dr. Stitt replied that it could be that the amounts of endotoxin
injected by Wood and King might not have been sufficiently large to invoke the direct
release ofPGE from the cells postulated to be in the OVLT.
Dr. Briick inquired whether theinabilityofneonatal animals to respond to pyrogens,
referred to by Dr. Kluger earlier, and the apparent role that arginine vasopressin
played in this refractoriness might be due to the effects of the AVP on the cells of the
OVLT described by Dr. Stitt. Dr. Blatteis stated that those studies which alleged that
AVP had antipyretic properties werecontroversial, since at least twootherlaboratories
had failed to confirm them.
Dr. Eisenman noted that Dr. Bernheim had presented evidence that cerebral cortex
tissue could be stimulated to release prostaglandins by IL-1 treatment in vitro and
asked whether this tissue contained macrophages or dendritic cells. Dr. Bernheim
replied that he did not think so, but it was known that both oligodendrocytes and
microglial cells possessed many of the properties of reticuloendothelial cells. These
cells had been shown, from the work of Fontana, to produce IL-I and PGE in vitro,
when stimulated by endotoxin. Dr. Atkins added that it was important to remember
that the number of cells in the body that are known to produce IL-I has gone far
beyond the macrophage, as we think of it in the blood, extending to the reticuloendo-
thelial system cells ofthe skin which he was told is the biggest immunological organ of
the body. Given this fact, Dr. Eisenman wondered which cells in brain tissue might
releasePGE in response to IL-1. Dr. Bernheim thought there were many and wondered
whether the microvascular epithelial cells may not be important also, since it is known
that these cells can produce prostanoids in response to a variety ofstimuli.
Dr. Coceani confirmed this fact and added that the brain as a whole in every site and
in many compartments could be stimulated to produce PGE2, but only certain sites in
the brain were physiologically responsive to the substance. He felt that the problem
hinged on whether the PGE reached a responsive site. He added that the work of
Fontana, quoted earlier, used cultured glial cells, the doses used were very high, and
the effect was verydelayed. Only after several hours did IL-I appear in the fluid. In his
own presentation earlier, he had mentioned that he could detect IL-I activity in the
cerebrospinal fluid in vivo, and there is an increase after intracerebroventricular
injection of endotoxin during the latent period of the fever. He does not yet know,
however, where this IL-I is coming from because when he injects endotoxin there is
pinocytosis, so that the IL-I may not come from the brain tissue itself, but it does have
access. Dr. Atkins asked whether it was known if microvascular tissue could produce
IL-1. Dr. Coceani replied that was their next project.
Dr. Duff inquired whether anyone knew of any mammalian cells, apart from
lymphocytes, that did not make prostaglandins in response to IL-1. When no one
replied, he said that this moved him further toward the beliefthat this was a universal
phenomenon and that was why hethought that the roleofthe OVLT was critical in the
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debate. Dr. Stitt agreed with the point made by both Dr. Duffand Dr. Coceani that the
site ofaction rather than the site ofrelease ofPGE was the critical point. That is why
he felt that the most recent data that he had obtained by injecting PGE directly into
the OVLT, which yielded a much greater fever sensitivity to PGE than either the
preoptic area or the cerebral ventricles, was so important.
Dr. Senay remarked that the OVLT region, along with the subfornical organ, had
been implicated in the regulation of body fluids and blood pressure. He wondered
whether the lesioned guinea pigs that Dr. Blatteis referred to earlier had showed any
deficits in normal temperature regulation, fluid intake, or blood pressure. Dr. Blatteis
replied "No," and Dr. Senay thought that this finding was strange.
Dr. Blatteis said that after listening to the debate held this morning he felt that the
weight of evidence did not contradict a role for prostaglandin E in the mediation of
fever, because noother substance has been described so far that produces a rise in body
temperature like an IL-I response. It may be, however, that prostaglandin is not the
mediator of everything that IL-1 does, because evidence exists that prostaglandin
inhibitors do not block the acute-phase reactions induced by IL-1.